2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build

2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 2022 CDC Clinical Practice Guideline - Profiles
... 3 2022 CDC Clinical Practice Guideline - Terminology
... 4 2022 CDC Clinical Practice Guideline - Examples
... 5 2022 CDC Clinical Practice Guideline - Documentation
.... 5.1 2022 CDC Clinical Practice Guideline - Implementation Documentation
.... 5.2 2022 CDC Clinical Practice Guideline - Integration Documentation
.... 5.3 2022 CDC Clinical Practice Guideline - Process Documentation
.... 5.4 2022 CDC Clinical Practice Guideline - Service Documentation
... 6 2022 CDC Clinical Practice Guideline - Downloads
... 7 2022 CDC Clinical Practice Guideline - Acute Pain
... 8 2022 CDC Clinical Practice Guideline - Quick Start
... 9 Chronic Pain Decision Documentation
... 10 Recommendation #1 - Nonpharmacologic and Nonopioid Pharmacologic Therapy Consideration
.... 10.1 OpioidCDS Recommendation 01 - CQL Source
... 11 Recommendation #2 - Opioid Therapy Goals Discussion
.... 11.1 OpioidCDS Recommendation 02 - CQL Source
... 12 Recommendation #3 - Opioid Immediate Release Form When Starting Opioid Therapy
.... 12.1 OpioidCDS Recommendation 03 - CQL Source
... 13 Recommendations #4 and #5 - Lowest Effective Dose
.... 13.1 OpioidCDS Recommendations 04 and 05 - CQL Source
... 14 Recommendation #6 - Prescribe Lowest Effective Dose and Duration
.... 14.1 OpioidCDS Recommendation 06 - CQL Source
... 15 Recommendation #7 - Opioid Therapy Risk Assessment
.... 15.1 OpioidCDS Recommendation 07 - CQL Source
... 16 Recommendation #8 - Naloxone Consideration
.... 16.1 OpioidCDS Recommendation 08 - CQL Source
... 17 Recommendation #9 - Consider Patient's History of Controlled Substance Prescriptions
.... 17.1 OpioidCDS Recommendation 09 - CQL Source
... 18 Recommendation #10 Order Sign Variation - Urine Drug Testing
.... 18.1 OpioidCDS Recommendation 10 Order Sign - CQL Source
... 19 Recommendation #10 Patient View Variation - Urine Drug Testing
.... 19.1 OpioidCDS Recommendation 10 Patient View - CQL Source
... 20 Recommendation #11 Order Select Variation - Concurrent Use of Opioids and Benzodiazepines
.... 20.1 OpioidCDS Recommendation 11 Order Select - CQL Source
... 21 Recommendation #11 Patient View Variation - Concurrent Use of Opioids and Benzodiazepines
.... 21.1 OpioidCDS Recommendation 11 Patient View - CQL Source
... 22 Recommendation #12 - Evidence-based Treatment for Patients with Opioid Use Disorder
.... 22.1 OpioidCDS Recommendation 12 (patient-view) - CQL Source
... 23 License and Legal Terms
... 24 Artifacts Summary
.... 24.1 HelloWorld
.... 24.2 HelloWorldPatientView
.... 24.3 CDCMMEClinicalConversionFactors
.... 24.4 OpioidCDSRoutines
.... 24.5 OpioidCDSCommon
.... 24.6 OpioidCDSCommonConfig
.... 24.7 OpioidLogicMK2020
.... 24.8 OpioidData2020
.... 24.9 FHIRHelpers
.... 24.10 FHIRModelInfo
.... 24.11 OpioidCDSREC10CommonLibrary
.... 24.12 OpioidCDSREC01Library
.... 24.13 OpioidCDSREC02Library
.... 24.14 OpioidCDSREC03Library
.... 24.15 OpioidCDSREC04And05Library
.... 24.16 OpioidCDSREC06Library
.... 24.17 OpioidCDSREC07Library
.... 24.18 OpioidCDSREC08Library
.... 24.19 OpioidCDSREC09Library
.... 24.20 OpioidCDSREC10Library
.... 24.21 OpioidCDSREC10PatientViewLibrary
.... 24.22 OpioidCDSREC11Library
.... 24.23 OpioidCDSREC11PatientViewLibrary
.... 24.24 OpioidCDSREC12PatientViewLibrary
.... 24.25 OpioidRiskAssessmentActivityDefinition
.... 24.26 OpioidUrineScreeningActivityDefinition
.... 24.27 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #1
..... 24.27.1 Library
.... 24.28 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #2
..... 24.28.1 Library
.... 24.29 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #3
..... 24.29.1 Library
.... 24.30 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendations #4 and #5
..... 24.30.1 Library
.... 24.31 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #6
..... 24.31.1 Library
.... 24.32 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #7
..... 24.32.1 Library
.... 24.33 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 (order-sign)
..... 24.33.1 Library
.... 24.34 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8
..... 24.34.1 Library
.... 24.35 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #9
..... 24.35.1 Library
.... 24.36 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (order-sign)
..... 24.36.1 Library
.... 24.37 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (patient-view)
..... 24.37.1 Library
.... 24.38 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10
..... 24.38.1 Library
.... 24.39 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 (patient-view)
..... 24.39.1 Library
.... 24.40 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11
..... 24.40.1 Library
.... 24.41 PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #12 (patient-view)
..... 24.41.1 Library
.... 24.42 Morphine Milligram Equivalent (MME) Conversion Factors for FHIR R4
.... 24.43 Morphine Milligram Equivalent (MME) Calculator for FHIR R4
.... 24.44 Opioid Management Terminology Knowledge Data
.... 24.45 Opioid Management Terminology Knowledge Logic
.... 24.46 CDC_CarePlan
.... 24.47 CDC_MedicationRequest
.... 24.48 CDC_Observation
.... 24.49 CDC_RequestGroup
.... 24.50 CDC_ValueSet
.... 24.51 DataDateRollerExtension
.... 24.52 EffectiveDataRequirement Extension
.... 24.53 CDC 2022 Opioid Guidance Clinical Focus Extension
.... 24.54 CDC 2022 Opioid Guidance Data Element Extension
.... 24.55 CDC 2022 Opioid Guidance exclusion Criteria Extension
.... 24.56 CDC 2022 Opioid Guidance Inclusion Criteria Extension
.... 24.57 CodeSystem - CDC 2022 Opioid Indicator
.... 24.58 OpioidCDS CarePlan
.... 24.59 Cancer Diagnosis Condition
.... 24.60 End of Life Condition
.... 24.61 Terminal Condition
.... 24.62 Cancer Diagnosis Encounter
.... 24.63 Oncology Participant Encounter
.... 24.64 Ambulatory Opioid MedicationDispense
.... 24.65 OpioidCDS MedicationRequest
.... 24.66 Ambulatory Opioid MedicationRequest
.... 24.67 OpioidCDS Observation
.... 24.68 OpioidCDS Patient
.... 24.69 Oncology Specialist PractitionerRole
.... 24.70 OpioidCDS RequestGroup
.... 24.71 Palliative Care ServiceRequest
.... 24.72 Ethanol urine drug screening tests
.... 24.73 Amphetamine-class drugs and metabolite urine tests
.... 24.74 Amphetamine class medications
.... 24.75 Benzodiazepine medications
.... 24.76 Buprenorphine and Methadone medications
.... 24.77 Cannabinoid class urine drug screening
.... 24.78 CDC malignant cancer conditions
.... 24.79 CNS depressant medications
.... 24.80 Cocaine urine drug screening tests
.... 24.81 Sleep disordered breathing
.... 24.82 Conditions documenting substance misuse
.... 24.83 Conditions likely terminal for opioid prescribing
.... 24.84 Extended release opioid with ambulatory misuse potential
.... 24.85 Fentanyl-type medications
.... 24.86 Fentanyl-type urine drug screening tests
.... 24.87 General opiate urine drug screening tests
.... 24.88 Hospice Finding
.... 24.89 Hospice Procedure
.... 24.90 Limited life expectancy conditions
.... 24.91 Methadone urine drug screening tests
.... 24.92 Methadone medications
.... 24.93 Naloxone medications
.... 24.94 Ambulatory setting non-opioid CNS depressant medications
.... 24.95 Non-opioid drug urine screening
.... 24.96 Non-synthetic opioid medications
.... 24.97 Oncology specialty designations (NUCC)
.... 24.98 Opiate specific urine drug screening tests
.... 24.99 Opioid analgesics with ambulatory misuse potential
.... 24.100 Opioid counseling procedure
.... 24.101 Opioid drug urine screening
.... 24.102 Opioid misuse assessment procedure
.... 24.103 Opioid misuse disorders
.... 24.104 Opioid treatment assessment procedure
.... 24.105 Pain management procedure
.... 24.106 Pain treatment plan
.... 24.107 PDMP data reviewed finding
.... 24.108 PDMP review procedure
.... 24.109 Phencyclidine urine drug screening tests
.... 24.110 Sickle-cell diseases
.... 24.111 Substance misuse behavioral counseling
.... 24.112 Synthetic opioid medications
.... 24.113 Synthetic opioid urine drug screening tests
.... 24.114 Therapies indicating end of life care
.... 24.115 Condition Clinical Status Active
.... 24.116 Encounter Diagnosis Condition Category
.... 24.117 Problem List Condition Category
.... 24.118 US Core Health Concern Condition Category
.... 24.119 Hospice Disposition
.... 24.120 Observation Category Laboratory
.... 24.121 Observation Category Procedure
.... 24.122 Office Visit
.... 24.123 CQFToolingDevice